EPMOBLE Trademark

Trademark Overview


On Tuesday, July 12, 2022, a trademark application was filed for EPMOBLE with the United States Patent and Trademark Office. The USPTO has given the EPMOBLE trademark a serial number of 97498760. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2026. This trademark is owned by Aquestive Therapeutics, Inc.. The EPMOBLE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations containing epinephrine for the treatment of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the treatment of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing epinephrine for the prevention of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the prevention of anaphylaxis, asthma, and allergic reactions.
epmoble

General Information


Serial Number97498760
Word MarkEPMOBLE
Filing DateTuesday, July 12, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations containing epinephrine for the treatment of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the treatment of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing epinephrine for the prevention of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the prevention of anaphylaxis, asthma, and allergic reactions.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAquestive Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
US

Party NameAquestive Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
US

Trademark Events


Event DateEvent Description
Friday, July 15, 2022NEW APPLICATION ENTERED
Monday, August 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 26, 2023ASSIGNED TO EXAMINER
Tuesday, May 9, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 9, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, May 9, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 9, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, May 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 5, 2024SOU EXTENSION 1 FILED
Friday, January 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 8, 2024SOU EXTENSION 2 FILED
Monday, July 8, 2024SOU EXTENSION 2 GRANTED
Monday, July 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 26, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 26, 2024SOU EXTENSION 3 FILED
Wednesday, November 27, 2024SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 29, 2025SOU TEAS EXTENSION RECEIVED
Thursday, May 29, 2025SOU EXTENSION 4 FILED
Thursday, May 29, 2025SOU EXTENSION 4 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 16, 2026ABANDONMENT - NO USE STATEMENT FILED
Monday, March 16, 2026ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED